CST2P1

Across TCGA pan-cancer cohorts, CST2P1 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated CST2P1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher CST2P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CST2P1 expression acts as an unfavorable survival marker.

KIRC and BLCA are the cancer types where CST2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
BLCA	DFS	Tertile	IV	0.122	0.469	.022	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CST2P1–KIRC (DFS)

Open the KIRC breakdown →